Incyte to acquire North Carolina drug developer in deal valued at up to $1.36 billion
October 03, 2022 at 10:20 AM EDT
The deal involving an experimental skin disorder drug includes an upfront payment of $70 million.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
